Fabian Koenigbauer's practice focuses on all aspects of domestic and international patent law, particularly in regards to the life sciences industry. His educational background in biochemistry and biotechnology, as well as his professional experience working with clients at all stages of product development, including products in pre-clinical trials and clinical trials, enables him to help clients develop their patent portfolios, assert their patent rights and defend against infringement allegations.
Fabian also routinely provides strategic counsel to clients on the processes of intellectual property transactions, including due diligences, portfolio development, licensing and litigation. He has particular expertise in developing and managing global patent portfolios in the life sciences industry. He has also represented clients in post-grant proceedings in the USPTO, including post-grant reviews. In addition, Fabian has asserted and defended patents through pre-litigation investigations, discovery, trials and appeals in the Federal Circuit. He has advised clients ranging from small companies and start-ups to Fortune 100 companies.